Microsomal epoxide hydrolase polymorphisms

Molecular Medicine Reports

Volumn 3, Issue 4, 2010, Pages 723-727

  Pinarbasi, Hatice ^a   Silig, Yavuz ^a   Pinarbasi, Ergun ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Microsomal epoxide hydrolase; Polymorphism

Indexed keywords

ARGININE DERIVATIVE; EPOXIDE HYDROLASE; HISTIDINE DERIVATIVE; TYROSINE DERIVATIVE;

ADULT; AGED; ARTICLE; BIOTRANSFORMATION; ENZYME ACTIVITY; EXON; FEMALE; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN EXPERIMENT; MALE; MOLECULAR EPIDEMIOLOGY; NORMAL HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TURKEY (REPUBLIC);

EID: 77956684345     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000324     Document Type: Article

References (42)

1. Adams JD Jr, Yagi H, Levin W and Jerina DM: Stereo-selectivity and regio-selectivity in the metabolism of 7,8-dihydrobenzo[a] pyrene by cytochrome P450, epoxide hydrolase and hepatic microsomes from 3-methylcholanthrene-treated rats. Chem Biol Interact 30: 57-77, 1995.
2. Seidegard J and Ekstrom G: The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics. Environ Health Perspect 4: 791-799, 1997.
3. Decker M, Arand M and Cronin A: Mammalian epoxide hydrolases in xenobiotic metabolism and signalling. Arch Toxicol 83: 297-318, 2009.
4. Szeliga J and Dipple A: DNA adduct formation by polycyclic aromatic hydrocarbon dihydrodiol epoxides. Chem Res Toxicol 11: 1-11, 1998.
5. Szeliga J and Amin S: Quantitative reactions of anti 5,9-dimethylchrysene dihydrodiol epoxide with DNA and deoxyribonucleotides. Chem Biol Interact 128: 159-172, 2000.
6. Seidegard J and DePierre JW: Microsomal epoxide hydrolase. Properties, regulation and function. Biochem Biophys Acta 29: 251-270, 1983.
7. Omiecinski CJ, Aicher L, Holubkov R and Checkoway H: Human peripheral lymphocytes as indicators of microsomal epoxide hydrolase activity in liver and lung. Pharmacogenetics 3: 150-158, 1993.
8. Skoda RC, Demierre A, McBride OW, Gonzalez FJ and Meyer UA: Human microsomal xenobiotic epoxide hydrolase. Complementary DNA sequence, complementary DNA-directed expression in COS-1 cells, and chromosomal localization. J Biol Chem 263: 1549-1554, 1988.
9. Hassett C, Robinson KB, Beck NB and Omiecinski CJ: The human microsomal epoxide hydrolase gene (EPHX1): complete nucleotide sequence and structural characterization. Genomics 23: 433-442, 1994.
10. Hassett C, Aicher L, Sidhu JS and Omiecinski CJ: Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3: 421-428, 1994.
11. Tranah GJ, Chan AT and Giovannucci E: Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the nurses' health study and the physicians' health study. Mol Carcinog 44: 21-30, 2005.
12. Lin TS, Huang HH, Fan YH, Chiou SH and Chow KC: Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer. Oncol Rep 17: 565-572, 2007.
13. Mittal RD and Srivastava DL: Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms: gene-environment interaction and risk of prostate cancer. DNA Cell Biol 26: 791-798, 2007.
14. Lee WJ, Brennan P, Boffetta P, London SJ, Benhamou S, Rannug A, To-Figueras J, Ingelman-Sundberg M, Shields P, Gaspari L and Taioli E: Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review. Biomarkers 7: 230-241, 2002. (Pubitemid 34678838)
15. Kiyohara C, Yoshimasu K, Takayama K and Nakanishi Y: EPHX1 polymorphisms and the risk of lung cancer: a HuGE review. Epidemiology 17: 89-99, 2006.
16. Miller SA, Dykes DD and Polesky HF: A simple salting-out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16: 1215, 1988.
17. Harms C, Salama SA, Torres CHS, Salazar NC and Au WW: Polymorphisms in DNA repair genes, chromosome aberrations, and lung cancer. Environ Mol Mutagen 44: 74-82, 2004.
18. Yim JJ, Park GY, Lee CT, Kim YW, Han SK, Shim YS and Yoo CG: Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax 55: 121-125, 2000.
19. Figueras JT, Gené M, Catalán JG, Piqué E, Borrego N, Caballero M, Cruellas F, Raya A, Dicenta M and Corbella J: Microsomal epoxide hydrolase and glutathione S-transferase polymorphisms in relation to laryngeal carcinoma risk. Cancer Lett 187: 95-101, 2002.
20. Ahmadi A, Fredrikson M, Jerregard H, Akerback A, Fall PA, Rannug A, Axelson O and Soderkvist P: GSTM1 and mEPHX polymorphisms in Parkinson's disease and age of onset. Biochem Biophys Res Commun 269: 676-680, 2000.
21. Van der Logt EMJ, Bergevoet SM, Roelofs HMJ, te Morsche HMR, van Dijk Y, Wobbes T, Nagengast FM and Peters WHM: Role of epoxide hydrolase, NAD(P)H: quinone oxidoreductase, cytochrome P450 2E1 or alcohol dehydrogenase genotypes in susceptibility to colorectal cancer. Mutat Res 593: 39-49, 2006.
22. Židzik J, Slabá S, Joppa P, Kluchová Z, Dorková Z, Skyba P, Habalová V, Šalagovič J and Tkáčová R: Glutathione S-transferase and microsomal epoxide hydrolase gene polymorphisms and risk of chronic obstructive pulmonary disease in Slovak population. Croat Med J 49: 182-191, 2008.
23. Casson AG, Zheng Z, Chiasson D, MacDonald K, Riddell DC, Guernsey JR, Guernsey DL and McLaughlin J: Associations between genetic polymorphisms of Phase I and II metabolizing enzymes, p53 and susceptibility to esophageal adenocarcinoma. Cancer Detect Prev 27: 139-146, 2003.
24. Gsur A, Zidek T, Schnattinger K, Feik E, Haidinger G, Hollaus P, Staudner AM, Armbruster C, Madersbacher S, Schatzl G, Trieb K, Vutuc C and Micksche M: Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer 89: 702-706, 2003.
25. Baxter SW, Choong DYH and Campbell IG: Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer. Cancer Lett 177: 75-81, 2002.
26. Takeyabu K, Yamaguchi E, Suzuki I, Nishimura M, Hizawa N and Kamakami Y: Gene polymorphism for microsomal epoxide hydrolase and susceptibility to emphysema in a Japanese population. Eur Respir J 15: 891-894, 2000.
27. Fu WP, Sun C, Dai LM, Yang LF and Zhang YP: Relationship between COPD and polymorphisms of HOX-1 and mEPH in a Chinese population. Oncol Rep 17: 483-488, 2007.
28. Sarmanova J, Benesova K, Gut I, Kristensen VN, Tynkova L and Soucek P: Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. Hum Mol Genet 10: 1265-1273, 2001.
29. Sonzogni L, Silvestri L, De Silvestri A, Gritti C, Foti L, Zavaglia C, Bottelli R, Mondelli MU, Civardi E and Silini EM: Polymorphisms of microsomal epoxide hydrolase gene and severity of HCV-related liver disease. Hepatology 36: 195-201, 2002.
30. Clavel J, Bellec S, Rebouissou S, Menegaux F, Feunteun J, Pellie CB, Baruchel A, Kebaili K, Lambilliotte A, Leverger G, Sommelet D, Lescoeur B, Beaune P, Hemon D and Loriot MA: Childhood leukaemia, polymorphisms of metabolism enzyme genes, and interactions with maternal tobacco, coffee and alcohol consumption during pregnancy. Eur J Cancer Prev 14: 531-540, 2005.
31. Laasanen J, Romppanen EL, Hiltunen M, Helisalmi S, Mannermaa A, Punnonen K and Heinonen S: Two exonic single nucleotide polymorphisms in the microsomal epoxide hydrolase gene are jointly associated with preeclampsia. Eur J Hum Genet 10: 569-573, 2002.
32. Ada AO, Suzen HS and Iscan M: Polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1 in a male Turkish population. Int J Toxicol 26: 41-46, 2007.
33. Morisseau C and Hammock BD: Epoxide hydrolases: mechanisms, inhibitor designs, and biological roles. Annu Rev Pharmacol Toxicol 45: 311-333, 2005.
34. Zeldin DC, Moomaw CR, Jesse N, Tomer KB, Beetham J, Hammock BD and Wu S: Biochemical characterization of the human liver cytochrome P450 arachidonic acid epoxygenase pathway. Arch Biochem Biophys 330: 87-96, 1996.
35. Oliw EH, Guengerich FP and Oates JA: Oxygenation of arachidonic acid by hepatic monooxygenases. Isolation and metabolism of four epoxide intermediates. J Biol Chem 257: 3771-3781, 1982.
36. Sandberg M, Hassett C, Adman ET, Meijer J and Omiecinski CJ: Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms. J Biol Chem 275: 28873-28881, 2000.
37. Przybyla-Zawislak BD, Srivastava PK, Vazquez-Matias J, Mohrenweiser HW, Maxwell JE, Hammock BD, Bradbury JA, Enayetallah AE, Zeldin DC and Grant DF: Polymorphisms in human soluble epoxide hydrolase. Mol Pharmacol 64: 482-490, 2003.
38. Fornage M, Boerwinkle E, Doris PA, Jacobs D, Liu K and Wong ND: Polymorphism of the soluble epoxide hydrolase is associated with coronary artery calcification in African-American subjects: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Circulation 109: 335-339, 2004.
39. Lee CR, North KE, Bray MS, Fornage M, Seubert JM, Newman JW, Hammock BD, Couper DJ, Heiss G and Zeldin DC: Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) study. Hum Mol Genet 15: 1640-1649, 2006.
40. Burdon KP, Lehtinen AB, Langefeld CD, Carr JJ, Rich SS, Freedman BI, Herrington D and Bowden DW: Genetic analysis of the soluble epoxide hydrolase gene, EPHX2, in subclinical cardiovascular disease in the Diabetes Heart Study. Diab Vasc Dis Res 5: 128-134, 2008.
41. Wei Q, Doris PA, Pollizotto MV, Boerwinkle E, Jacobs DR Jr, Siscovick DS and Fornage M: Sequence variation in the soluble epoxide hydrolase gene and subclinical coronary atherosclerosis: interaction with cigarette smoking. Atherosclerosis 190: 26-34, 2007.
42. Gschwendtner A, Ripke S, Freilinger T, Lichtner P, Müller-Myhsok B, Wichmann HE, Meitinger T and Dichgans M: Genetic variation in soluble epoxide hydrolase (EPHX2) is associated with an increased risk of ischemic stroke in white Europeans. Stroke 39: 1593-1596, 2008.